PASADENA, Calif., Oct. 30 /PRNewswire/ -- Clinical Micro Sensors (CMS), a business unit of Motorola, Inc., (NYSE: MOT), will unveil commercial versions of its eSensor(TM) DNA detection system and demonstrate its ability to do DNA testing relevant to healthcare, agriculture, food safety, animal health and breeding, or environmental monitoring. eSensor(TM) technology represents a futuristic advance in DNA analysis with the potential to lower the cost, improve the quality, and speed-the-time to market of DNA tests. The technology has been shown effective in studies detecting panels of bacterial or viral targets, genetically modified crops (GMOs), and SNPs (single nucleotide polymorphisms), the most common form of genetic mutation in human, plants, and animals. The eSensor(TM) system relies on bioelectronics, a major advance in DNA analysis that will broaden the use of DNA tests to allow improved health and safety. Bioelectronics uses organic molecules to form electronic circuit elements that detect and quantify many different DNA and RNA targets at once. The ability to offer a panel of tests, producing clear, unambiguous results, will reduce the cost and increase the sophistication of practical DNA testing. CMS expects manufacturing and shipping the first benchtop eSensor(TM) instruments during the second quarter of 2001 for research and nonhuman diagnostics markets such as agriculture and animal health and breeding. In the future, CMS intends to deliver its technology for use in clinical laboratories, point-of-care settings, and physician offices. CMS will demonstrate eSensor(TM) DNA detection technology at International Business Communications' (IBC) Annual Biochip Technologies Conference, Chips To Hits, on Tuesday, November 7, 2000 at the Philadelphia Marriott Downtown in Philadelphia, Pennsylvania. IBC's Chips To Hits event has continually grown to become the largest annual gathering for chip technologies in the pharmaceutical and biotechnology industries. More information regarding CMS' demonstration at the Chips To Hits conference is available at www.microsensor.com. About Motorola Motorola, Inc. is a global leader in providing integrated communications solutions and embedded electronic solutions. Sales in 1999 were $33.1 billion. Additional corporate information is available at www.motorola.com. Clinical Micro Sensors, a division of Motorola, is a leader in the field of mass applied genomics -- the widespread application of genetic knowledge to medicine and industry. CMS is developing DNA detection units and disposable biochip cartridges, combining universal platform design and advanced bioelectronic technology. The CMS eSensor(TM) system is poised to set new standards for rapid, cost-effective DNA analysis in healthcare, agriculture, food safety, animal health and breeding, and environmental monitoring. Motorola and the Motorola logo are registered trademarks of Motorola, Inc.
SOURCE Clinical Micro Sensors